Aspect Biosystems

An award-winning biotechnology company operating on the leading edge of 3D bioprinting and tissue engineering.

Aspect has developed a disruptive 3D bioprinting platform based on its proprietary Lab-on-a-Printer technology, capable of creating living Human Tissues on Demand for broad applications in the life sciences. Aspect’s technology is enabling advances in fundamental biology, drug development through novel pre-clinical models, and regenerative medicine where in the future, lifesaving transplant organs will be created, not harvested.